Population Diagnostics to Discuss Autism Diagnostic Breakthroughs at the 2007 Life Sciences Industry Summit

MELVILLE, NY--(MARKET WIRE)--Jun 11, 2007 -- Population Diagnostics, Inc. announced today that Jim Chinitz, the company's CEO, will present a corporate overview at the 2007 Life Sciences Industry Summit to be held on June 14th at the Huntington Hilton in Melville, NY. Mr. Chinitz is an invited speaker by the sponsors, the Long Island Life Sciences Initiative (LILSI) and the New York State Center for Biotechnology. The overview will emphasize their novel approach to revealing causative biomarkers for human disease, which are the key ingredients to developing DNA-based diagnostics and personalized medicine tests with the highest level of clinical value. The presentation will include information about its prototype platform, which has revealed causative biomarkers for Autism, paving the way for the development of a screening test.